𝔖 Bobbio Scriptorium
✦   LIBER   ✦

56 CISPLATIN VERSUS CARBOPLATIN-BASED REGIMENS IN THE FIRST-LINE TREATMENT OF SMALL CELL LUNG CANCER (SCLC): META-ANALYSIS OF PUBLISHED RANDOMIZED CLINICAL TRIALS (RCTS)

✍ Scribed by A. Rossi; M. Di Maio; O. Martelli; M.C. Garassino; P. Maione; C. Gridelli

Book ID
117487956
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
58 KB
Volume
36
Category
Article
ISSN
0305-7372

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

An International, Multicenter, Randomize
An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial
✍ Cesare Gridelli; Charles Butts; Fortunato Ciardiello; Ronald Feld; Ciro Gallo; F πŸ“‚ Article πŸ“… 2008 πŸ› CIG Media Group, LP. 🌐 English βš– 91 KB